November 2023 - Page 4 of 5 - CannabisNewsWire

ThursdayNov 09, 2023 4:20 am

420 with CNW — Connecticut Doubles Recreational Cannabis Purchase Limit

Beginning in December, adults in the state of Connecticut will be allowed to buy up to one-half an ounce of cannabis in one retail transaction. This comes after the state doubled its purchase limit from quarter of an ounce of marijuana. The state’s Department of Consumer Protection announced the scheduled increase last week, explaining that it was the result of a continuing analysis of demand and supply and was designed to make certain businesses maintain sufficient supply for both medical cannabis patients and adult-use consumers. It should be noted, however, that the limits imposed on medical cannabis remain unchanged. The…

WednesdayNov 08, 2023 4:20 pm

420 with CNW — University of Buffalo Professor Receives $3.2M Grant to Study Cannabis Among Cancer Patients

The National Institutes of Health's (NIH) National Cancer Institute has allocated $3.2 million to fund a study exploring the impact of marijuana use on cancer patients undergoing immunotherapy treatment. The grant, announced by the University of Buffalo (UB), aims to conduct a comprehensive yearlong examination of how cannabis use by cancer patients affects their response to conventional cancer treatments. Specifically, the study focuses on patients undergoing immunotherapy, a treatment known for its reduced side effects compared to chemotherapy. Speaking at a National Academies of Sciences, Engineering, and Medicine (NASEM) meeting last month, an NCI representative expressed the organization's desire to…

WednesdayNov 08, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Patented DehydraTECH(TM) Technology’s Effectiveness on GLP-1 Drugs for Potential Diabetes Treatment and Weight Loss

Lexaria, a global innovator in drug delivery platforms, recently announced plans to launch new human and animal studies examining whether its patented DehydraTECH(TM) technology can make GLP-1 drugs better Lexaria has previously demonstrated DehydraTECH’s overall potential in its DIAB-A22-1 animal study, which yielded weight loss, and improved triglyceride and cholesterol levels among diabetic-conditioned animals The company plans to replicate the results from this study while also exploring ways to improve the overall bioavailability of GLP-1 drugs for diabetes treatment and weight loss Lexaria management is optimistic that it will build on previous studies, replicate previous positive results, and improve the…

WednesdayNov 08, 2023 4:20 am

420 with CNW — Study Finds Increase in Traffic Fatalities in Prohibitionist States, Drop Where Cannabis Is Legal

A new study from Quartz Advisor has found states that legalized cannabis since 2016 registered a “meaningful decline” in traffic fatalities. Interestingly, the paper found that states that have continued to criminalize cannabis possession and use have seen a slight increase in traffic fatalities. The study goes against the notion that legalizing cannabis would lead to higher rates of driving under the influence and result in more traffic fatalities. While prohibitionists argued that legalizing cannabis would prove to be a danger to the public, this study suggests that ending cannabis prohibition may have a connection with fewer traffic accidents and…

TuesdayNov 07, 2023 4:20 pm

420 with CNW — Minnesota University-Led Study Uncovers Medical Marijuana Usage Patterns

Research led by the University of Minnesota in partnership with Vireo Health looked into patterns of medical marijuana consumption and use. Currently, the medical use of marijuana is legal in 38 states in the United States, the federal District of Columbia and 4 inhabited territories. Despite the rising use of medical marijuana, state-cannabis programs don’t have consistent guidelines governing products being consumed by patients, particularly for THC and CBD. CBD (cannabidiol) and THC (tetrahydrocannabinol) are the two primary compounds found in marijuana. While THC does induce a high when consumed, CBD does not. Both compounds interact with the body differently,…

TuesdayNov 07, 2023 4:20 am

420 with CNW — Georgia Pharmacies Start Selling Medical Marijuana Oil

Oct. 27, 2023, marked the first day of medical cannabis sales at independent pharmacies in Georgia, with Robin’s Pharmacy, Allen Pharmacy Group and Omega Pharmacy becoming the first to secure state licenses for the sale of low-THC (less than 5% concentration) medical cannabis products. Dr. Ankit Patel of Robins Pharmacy expressed his excitement, calling it a historic moment. He had been closely monitoring the development of the state’s cannabis laws for about four years, eagerly awaiting the opportunity for independent pharmacies to stock these products. To gain state approval, pharmacies need to undergo inspections by the Georgia Drugs & Narcotics…

MondayNov 06, 2023 4:20 pm

420 with CNW — Massachusetts Marijuana Firms Challenge Federal Ban on Cannabis

Last week, an alliance of marijuana companies in the state of Massachusetts filed a lawsuit that challenges the federal prohibition of cannabis as it applies to individual states. Currently, marijuana remains classified as a Schedule I substance under the Controlled Substances Act. This is despite the fact that the medical use of marijuana is legal in 38 states, 4 U.S. territories and the federal District of Columbia. Adult-use marijuana is also legal in 23 states, 3 U.S. territories and D.C. The Controlled Substances Act was enacted by the 91st United States Congress and signed into law by President Richard Nixon…

MondayNov 06, 2023 4:20 am

420 with CNW — Brazilian Scientists Find Cannabis Compound Inside Unrelated Plant

Researchers have discovered that a common plant in Brazil contains the cannabis ingredient cannabidiol (CBD). This discovery creates new opportunities for the production of the well-known substance from alternative sources. A group of scientists from the Federal University of Rio de Janeiro uncovered CBD in the flowers and fruits of the Tremamicranthablume (trema) plant, a common shrub found throughout Brazil. According to lead scientist Rodrigo Moura Neto, the plant, which is sometimes categorized as a weed, is a promising source of CBD. CBD, recognized for its potential in managing anxiety, chronic pain and epilepsy, stands as a key active component…

FridayNov 03, 2023 4:20 pm

420 with CNW — Cannabis Legalization Causes Major Drug Test Manufacturer to Replace Tests with Fentanyl

Psychemedics, a leading drug-testing technology manufacturer, has unveiled an innovative screening panel that diverges from detecting cannabis, instead focusing on fentanyl and other controlled drugs, as a response to the shifting landscape due to the legalization of cannabis in numerous states. Psychemedics' updated Advanced 5-Panel Drug Screen marks a transformative step in how companies safeguard their places of work by shifting focus from cannabis to the major threat posed by fentanyl. The revamped screening panel has garnered approval from the Food & Drug Administration (FDA) and is celebrated for its enhanced accuracy in identifying amphetamines, PCP, opioids and cocaine. Psychemedics,…

FridayNov 03, 2023 4:20 am

420 with CNW — Feds Fund Central Research Center to Combat Barriers to Cannabis Research

Recently, the National Institutes of Health posted a funding opportunity notice stating that it sought an eligible body to operate a new center for marijuana and cannabinoid research via a cooperative agreement. The centralized cannabis research center would be designed to help researchers overcome barriers to studying cannabis amid federal prohibition. This is in addition to allowing scientists to generate more scientific evidence across various research domains in clinical and basic research. Addressing barriers in cannabis research has been a priority for many federal health agencies as researchers continue to be subjected to costly and taxing registration processes in order…